TYMONCLA Trademark

Trademark Overview

On Wednesday, January 7, 2026, a trademark application was filed for TYMONCLA with the United States Patent and Trademark Office. The USPTO has given the TYMONCLA trademark a serial number of 99581453. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, January 7, 2026. This trademark is owned by AstraZeneca AB. The TYMONCLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Pharmaceutical preparations for the treatment of antibodies; Vaccines
tymoncla

General Information

Serial Number99581453
Word MarkTYMONCLA
Filing DateWednesday, January 7, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, January 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Pharmaceutical preparations for the treatment of antibodies; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 7, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type64 - NOT AVAILABLE
AddressSodertalje SE-15185
SE

Trademark Events

Event DateEvent Description
Wednesday, January 7, 2026NEW APPLICATION ENTERED
Wednesday, January 7, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 7, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

tymoncla pharmaceutical preparations treatment disorders diseases inflammation systems infection hematological antibodies